相关实验视频
Updated: Mar 7, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.3K
检查先天性心脏病儿科患者的适应性功能
Corinne M Anton1,2,3, Kelli N Triplett2,3,4, Ila A Iverson2
1Department of Cardiology, Children's Health - Children's Medical Center, Dallas, TX, USA.
概括
患有先天性心脏病的幼儿通常表现出较低的适应能力,影响日常生活. 这项研究强调了适应性功能,认知能力和遗传综合征和父母教育等因素之间的联系.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 神经发育科学 神经发育科学
- 儿童心理学 儿童心理学
背景情况:
- 先天性心脏病 (CHD) 与儿童的神经发育障碍有关.
- 适应性功能对独立性和生活质量至关重要,但在患有心脏病的幼儿中尚不清楚.
- 早期识别和对适应能力的支持对这一群体至关重要.
研究的目的:
- 描述具有先天性心脏病史的幼儿 (2-5岁) 的适应性功能.
- 检查这个群体的适应能力,发育状态和认知能力之间的关系.
- 识别与适应性功能变化相关的因素.
主要方法:
- 对104名患有心脏病的儿童 (年龄为2-5岁) 的临床注册数据的回顾性分析.
- 在心脏神经发育计划中评估的英语单语和西班牙语双语参与者的纳入.
- 利用适应性,发育性和认知功能的标准化措施;采用描述性和相关性分析.
主要成果:
- 适应能力和认知能力通常在低平均值下降到平均值以下的范围.
- 在适应能力和发展和认知功能之间发现了显著的关联.
- 较低的适应能力与遗传综合征相关;与父母教育相关的更高的适应能力. 女人表现出更高的概念技能.
结论:
- 患有心血管疾病的幼儿在适应性功能方面表现出挑战,这与他们的认知和发育概况密切相关.
- 遗传综合征和父母教育是影响这个群体适应能力的重要因素.
- 这些发现强调了需要有针对性的干预措施,以支持患有心脏病的儿童的适应性发展.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
588
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy V: Interprofessional Care
558
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Heart Failure VI: Adjunct Therapies
488
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
488
Cardiomyopathy II: Dilated Cardiomyopathy
687
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Heart Failure V: Medical Management
441
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
441

